Topical Rapamycin for Fibrofolliculomas

Clinical trial NCT00928798 · COMPLETED

Trial details

NCT number: NCT00928798
Sponsor: Maastricht University Medical Center
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Birt-Hogg-Dubé Syndrome

Start date: 2010-01-01
Primary completion: 2011-02-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.